Go Pro

Arcturus Therapeutics (ARCT) Earnings Date, Estimates & Call Transcripts

Arcturus Therapeutics logo
$6.08 -0.18 (-2.88%)
Closing price 08/6/2026 04:00 PM Eastern
Extended Trading
$6.22 +0.14 (+2.35%)
As of 08/6/2026 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Arcturus Therapeutics Earnings Summary

Arcturus Therapeutics posted Q2 2026 earnings on August 6, 2026, reporting an EPS of -$0.84, which topped the consensus estimate of -$1.00 by $0.16. Quarterly revenue was reported to be $2.96 million, below the consensus estimate of $3.11 million. With a trailing EPS of -$2.81, Arcturus Therapeutics' earnings are expected to grow next year, from ($3.99) to ($3.86) per share.

Latest Q2
Earnings Date
Aug. 6Confirmed
Consensus EPS
(Aug. 6)
-$1.00
Actual EPS
(Aug. 6)
-$0.84 Beat By $0.16
Actual Revenue
(Aug. 6)
$2.96M

Q2 2026 Earnings Resources

Get Arcturus Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcturus Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ARCT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ARCT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Arcturus Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.82-$0.70-$0.76
Q2 20262-$0.99-$0.85-$0.92
Q3 20262-$0.94-$0.92-$0.93
Q4 20262-$0.91-$0.88-$0.90

Arcturus Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026-$0.9964-$0.84+$0.1564-$0.84$3.11M$2.96M
5/8/2026Q1 2026-$1.0320-$0.95+$0.0820-$0.95$6.30M$2.06M
3/3/2026Q4 2025-$0.92-$1.03 -$0.11-$1.0230$14.32M$7.20M
11/10/2025Q3 2025-$1.09-$0.49+$0.60-$0.49$17.47M$17.15M
8/11/2025Q2 2025-$1.11-$0.34+$0.77-$0.34$17.64M$28.30M
5/12/2025Q1 2025-$1.58-$0.52+$1.06-$0.52$25.64M$29.38M
3/6/2025Q4 2024-$0.33-$1.11 -$0.78-$1.11$44.64M$22.77M
11/7/2024Q3 2024-$0.70-$0.26+$0.44-$0.26$49.16M$41.67M

Arcturus Therapeutics Earnings - Frequently Asked Questions

Arcturus Therapeutics has confirmed that its next quarterly earnings data will be published on Thursday, August 6th, 2026. Learn more on ARCT's earnings history.

In the previous quarter, Arcturus Therapeutics (NASDAQ:ARCT) reported ($0.95) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.03) by $0.08. Learn more on analysts' earnings estimate vs. ARCT's actual earnings.

The conference call for Arcturus Therapeutics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Arcturus Therapeutics' latest earnings report can be read online.
Read Transcript

Arcturus Therapeutics (NASDAQ:ARCT) has a recorded annual revenue of $82.03 million.

Arcturus Therapeutics (NASDAQ:ARCT) has a recorded net income of -$65.78 million. ARCT has generated -$2.81 earnings per share over the last four quarters.

Arcturus Therapeutics' earnings are expected to grow from ($3.99) per share to ($3.86) per share in the next year.


Earnings data for NASDAQ:ARCT is sourced from Fiscal.ai, with the most recent quarter reported on 8/6/2026. New results are added as companies report their earnings.
From Our Partners